{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:12:31Z","timestamp":1778767951685,"version":"3.51.4"},"reference-count":44,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background\/Objectives: Multidrug-resistant tuberculosis (MDR-TB) remains a major public health challenge in the WHO European Region, which reports the highest global proportion of rifampicin-resistant and MDR-TB cases. Whole-genome sequencing (WGS) has emerged as a key tool for improving drug-resistance detection and supporting molecular surveillance. However, the level of genomic implementation across Central and Eastern Europe (CEE) remains insufficiently characterized. This scoping review aimed to evaluate the use of WGS for MDR-TB in CEE countries and to classify implementation maturity using a predefined framework (L0\u2013L4). Methods: A structured search of PubMed\/MEDLINE and Web of Science identified original studies published in English between 2015 and 2026 reporting genomic applications in MDR-TB across 13 predefined CEE countries. Data were extracted on sequencing approaches, resistance prediction, transmission analysis, monitoring of new or repurposed drugs, bioinformatic pipelines, and programmatic integration. Countries were categorized according to a five-level maturity model based on documented capacity, scope of application, and integration into national tuberculosis programs (NTPs). Results: Twenty-eight studies were included. WGS was used in 23\/28 studies (82.1%), predominantly for genomic resistance prediction (25\/28). Transmission analysis was reported in 19\/28 studies, with heterogeneous single nucleotide polymorphism (SNP) thresholds and clustering methodologies. Monitoring of resistance to new or repurposed drugs was described in 8\/28 studies. No country achieved Level L4 (formally integrated genomic surveillance). Four countries were classified as L3 and nine as L2, while no L0 or L1 settings were identified. Conclusions: Countries in Central and Eastern Europe demonstrate increasing operational use of WGS for MDR-TB, primarily driven by clinical resistance prediction. However, the lack of formal integration into national surveillance systems highlights a persistent gap between technological adoption and structured public health implementation. Strengthening programmatic integration and methodological standardization is essential for advancing genomic surveillance of MDR-TB in the region.<\/jats:p>","DOI":"10.3390\/diseases14050172","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:04:09Z","timestamp":1778763849000},"page":"172","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidrug-Resistant Tuberculosis in Central and Eastern Europe: Implementation and Maturity of Whole-Genome Sequencing for Surveillance"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1219-0011","authenticated-orcid":false,"given":"Dragos","family":"Baiceanu","sequence":"first","affiliation":[{"name":"Doctoral School, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Research, Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Ioana","family":"Chivu","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Midwifery and Nursing, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana-Mihaela","family":"Coriu","sequence":"additional","affiliation":[{"name":"Doctoral School, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Clinical Laboratory of Medical Microbiology, Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-2618","authenticated-orcid":false,"given":"Alexandru","family":"Stoichita","sequence":"additional","affiliation":[{"name":"Doctoral School, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Research, Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Traian-Constantin","family":"Panciu","sequence":"additional","affiliation":[{"name":"Doctoral School, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Research, Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9122-6862","authenticated-orcid":false,"given":"Dragos-Cosmin","family":"Zaharia","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoracic Pathology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Pulmonology, Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9240-922X","authenticated-orcid":false,"given":"Beatrice","family":"Mahler","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoracic Pathology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Pulmonology, Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Matei","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-2087","authenticated-orcid":false,"given":"Elmira","family":"Ibraim","sequence":"additional","affiliation":[{"name":"Department of Research, Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8694-6195","authenticated-orcid":false,"given":"Loredana Sabina Cornelia","family":"Manolescu","sequence":"additional","affiliation":[{"name":"Clinical Laboratory of Medical Microbiology, Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania"},{"name":"Department of Fundamental Sciences, Faculty of Midwifery and Nursing, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"ref_1","unstructured":"WHO (2024). Global Tuberculosis Report 2024, WHO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1038\/s41467-022-32455-1","article-title":"Transcontinental Spread and Evolution of Mycobacterium Tuberculosis W148 European\/Russian Clade toward Extensively Drug Resistant Tuberculosis","volume":"13","author":"Merker","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9676","DOI":"10.1038\/s41598-018-27962-5","article-title":"Linking Minimum Inhibitory Concentrations to Whole Genome Sequence-Predicted Drug Resistance in Mycobacterium Tuberculosis Strains from Romania","volume":"8","author":"Ruesen","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2002272","DOI":"10.1183\/13993003.02272-2020","article-title":"Use of a Whole Genome Sequencing-Based Approach for Mycobacterium Tuberculosis Surveillance in Europe in 2017-2019: An ECDC Pilot Study","volume":"57","author":"Tagliani","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_5","first-page":"2300583","article-title":"Characteristic SNPs Defining the Major Multidrug-Resistant Mycobacterium Tuberculosis Clusters Identified by EuSeqMyTB to Support Routine Surveillance, EU\/EEA, 2017 to 2019","volume":"29","author":"Tagliani","year":"2024","journal-title":"Eurosurveillance"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100471","DOI":"10.1016\/j.epidem.2021.100471","article-title":"Quantifying Transmission Fitness Costs of Multi-Drug Resistant Tuberculosis","volume":"36","author":"Meehan","year":"2021","journal-title":"Epidemics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"134","author":"Page","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1128\/JCM.00486-15","article-title":"Rapid Whole-Genome Sequencing of Mycobacterium Tuberculosis Isolates Directly from Clinical Samples","volume":"53","author":"Brown","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10096-014-2202-z","article-title":"A Close-up on the Epidemiology and Transmission of Multidrug-Resistant Tuberculosis in Poland","volume":"34","author":"Jagielski","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"30439","DOI":"10.2807\/1560-7917.ES.2017.22.2.30439","article-title":"A Joint Cross-Border Investigation of a Cluster of Multidrug-Resistant Tuberculosis in Austria, Romania and Germany in 2014 Using Classic, Genotyping and Whole Genome Sequencing Methods: Lessons Learnt","volume":"22","author":"Fiebig","year":"2017","journal-title":"Eurosurveillance"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1017\/S095026881800047X","article-title":"Cross-Border Outbreak of Extensively Drug-Resistant Tuberculosis Linked to a University in Romania","volume":"146","author":"Popovici","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e00009-18","DOI":"10.1128\/JCM.00009-18","article-title":"Next-Generation Sequencing for Characterizing Drug Resistance-Conferring Mycobacterium Tuberculosis Genes from Clinical Isolates in the Ukraine","volume":"56","author":"Daum","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sinkov, V., Ogarkov, O., Mokrousov, I., Bukin, Y., Zhdanova, S., and Heysell, S.K. (2018). New Epidemic Cluster of Pre-Extensively Drug Resistant Isolates of Mycobacterium Tuberculosis Ural Family Emerging in Eastern Europe. BMC Genom., 19.","DOI":"10.1186\/s12864-018-5162-3"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.diagmicrobio.2018.10.018","article-title":"Characterization of Novel Mycobacterium Tuberculosis PncA Gene Mutations in Clinical Isolates from the Ukraine","volume":"93","author":"Daum","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wollenberg, K., Harris, M., Gabrielian, A., Ciobanu, N., Chesov, D., Long, A., Taaffe, J., Hurt, D., Rosenthal, A., and Tartakovsky, M. (2020). A Retrospective Genomic Analysis of Drug-Resistant Strains of M. Tuberculosis in a High-Burden Setting, with an Emphasis on Comparative Diagnostics and Reactivation and Reinfection Status. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-019-4739-z"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jgar.2020.03.013","article-title":"Frequency of Mutations Associated with Resistance to First- and Second-Line Drugs in Multidrug-Resistant Mycobacterium Tuberculosis Isolates","volume":"22","author":"Bitar","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3201\/eid2603.190525","article-title":"Multidrug- And Extensively Drug-Resistant Mycobacterium Tuberculosis Beijing Clades, Ukraine, 2015","volume":"26","author":"Merker","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"104126","DOI":"10.1016\/j.meegid.2019.104126","article-title":"Analysis of Mycobacterium Tuberculosis Genetic Lineages Circulating in Riga and Riga Region, Latvia, Isolated between 2008 and 2012","volume":"78","author":"Pole","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/tbed.13758","article-title":"Spatiotemporal Dynamics of Drug-Resistant Mycobacterium Tuberculosis: Contrasting Trends and Implications for Tuberculosis Control in EU High-Priority Country","volume":"68","author":"Mokrousov","year":"2021","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1900677","DOI":"10.2807\/1560-7917.ES.2021.26.2.1900677","article-title":"Improving Tuberculosis Surveillance by Detecting International Transmission Using Publicly Available Whole Genome Sequencing Data","volume":"26","author":"Sanchini","year":"2021","journal-title":"Eurosurveillance"},{"key":"ref_22","first-page":"000620","article-title":"Evolution and Emergence of Multidrug-Resistant Mycobacterium Tuberculosis in Chisinau, Moldova","volume":"7","author":"Brown","year":"2021","journal-title":"Microb. Genom."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1038\/s41598-022-11287-5","article-title":"Whole Genome Sequencing of Multidrug-Resistant Mycobacterium Tuberculosis Isolates Collected in the Czech Republic, 2005\u20132020","volume":"12","author":"Spitaleri","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3897\/folmed.64.e70554","article-title":"Whole Genome Sequencing of Bulgarian Rifampicin Resistant Mycobacterium Tuberculosis Strains","volume":"64","author":"Yordanova","year":"2022","journal-title":"Folia Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2100621","DOI":"10.1183\/13993003.00621-2021","article-title":"Emergence of Bedaquiline Resistance in a High Tuberculosis Burden Country","volume":"59","author":"Chesov","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100292","DOI":"10.1016\/j.jctube.2021.100292","article-title":"Anti-Tuberculosis Drug Resistance in Slovakia, 2018\u20132019: The First Whole-Genome Epidemiological Study","volume":"26","author":"Cabibbe","year":"2022","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Yang, C., Sobkowiak, B., Naidu, V., Codreanu, A., Ciobanu, N., Gunasekera, K.S., Chitwood, M.H., Alexandru, S., Bivol, S., and Russi, M. (2022). RESEARCH ARTICLE Phylogeography and Transmission of M. Tuberculosis in Moldova: A Prospective Genomic Analysis. PLoS Med., 19.","DOI":"10.1371\/journal.pmed.1003933"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Baku\u0142a, Z., Marczak, M., Bluszcz, A., Proboszcz, M., Ko\u015bciuch, J., Krenke, R., Stak\u0117nas, P., Mokrousov, I., and Jagielski, T. (2023). Phylogenetic Relationships of Mycobacterium Tuberculosis Isolates in Poland: The Emergence of Beijing Genotype among Multidrug-Resistant Cases. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1161905"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3201\/eid2905.230035","article-title":"Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova","volume":"29","author":"Noroc","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Viksna, A., Sadovska, D., Berge, I., Bogdanova, I., Vaivode, A., Freimane, L., Norvai\u0161a, I., Ozere, I., and Ranka, R. (2023). Genotypic and Phenotypic Comparison of Drug Resistance Profiles of Clinical Multidrug-Resistant Mycobacterium Tuberculosis Isolates Using Whole Genome Sequencing in Latvia. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08629-7"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100493","DOI":"10.1016\/j.jctube.2024.100493","article-title":"Endogenous Reactivation Cases Identified by Whole Genome Sequencing of Mycobacterium Tuberculosis: Exploration of Possible Causes in Latvian Tuberculosis Patients","volume":"37","author":"Viksna","year":"2024","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_32","first-page":"35","article-title":"Tuberculosis in Ukrainian War Refugees and Migrants in the Czech Republic and Slovakia: A Molecular Epidemiological Study","volume":"14","author":"Ghodousi","year":"2024","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2500838","DOI":"10.2807\/1560-7917.ES.2025.30.46.2500838","article-title":"Tracking the Evolution of an Extensively Drug-Resistant Cross-Border Mycobacterium Tuberculosis Cluster, Europe, January 2016 up to August 2025: Implications for European Surveillance","volume":"30","author":"Saluzzo","year":"2025","journal-title":"Eurosurveillance"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Minias, A., Fiedorowicz, L., Kozi\u0144ska, M., Zabost, A., Lach, J., S\u0142omka, M., Strapagiel, D., Dziadek, J., and Augustynowicz-Kope\u0107, E. (2025). Nationwide Whole-Genome Sequencing Reveals Local Transmission of Mycobacterium Tuberculosis in Poland, 2003\u20132020. BMC Infect. Dis., 26.","DOI":"10.1186\/s12879-025-12438-5"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"108203","DOI":"10.1016\/j.ijid.2025.108203","article-title":"Application of Whole-Genome Sequencing for Distinguishing Relapse from Reinfection in Tuberculosis Patients from Lithuania","volume":"162","author":"Zinola","year":"2026","journal-title":"Int. J. Infect. Dis."},{"key":"ref_36","unstructured":"European Centre for Disease Prevention and Control (2025). 2025 Tuberculosis Surveillance and Monitoring in Europe 2025."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Andr\u00e9s, M., Van Der Werf, M.J., K\u00f6dm\u00f6n, C., Albrecht, S., Haas, W., Fiebig, L., Indra, A., Wanlin, M., Bachiyska, E., and Jurcev-Savicevic, A. (2019). Molecular and Genomic Typing for Tuberculosis Surveillance: A Survey Study in 26 European Countries. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210080"},{"key":"ref_38","unstructured":"European Centre for Disease Prevention and Control (2023). Tuberculosis Molecular Surveillance Status Report, Focusing on Rifampicin and Multi-Drug Resistance in the EU\/EEA."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102185","DOI":"10.1016\/j.tube.2022.102185","article-title":"Utility of the Whole Genome Sequencing Based Methodologies in Routine European Tuberculosis Reference Laboratory Network Setting","volume":"134","author":"Holicka","year":"2022","journal-title":"Tuberculosis"},{"key":"ref_40","unstructured":"WHO (2025). Consolidated Guidelines on Tuberculosis Module 3: Diagnosis, WHO."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.cmi.2019.03.022","article-title":"Role and Value of Whole Genome Sequencing in Studying Tuberculosis Transmission","volume":"25","author":"Nikolayevskyy","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"van der Werf, M.J., and K\u00f6dm\u00f6n, C. (2019). Whole-Genome Sequencing as Tool for Investigating International Tuberculosis Outbreaks: A Systematic Review. Front. Public Health, 7.","DOI":"10.3389\/fpubh.2019.00087"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mitroi, D.M., Balteanu, M.A., Cioboata, R., Vlasceanu, S.G., Zlatian, O.M., Catana, O.M., Mirea, A.A., Mogos, G.F.R., Rotaru, I., and Biciusca, V. (2025). Hypercoagulability in Tuberculosis: Pathophysiological Mechanisms, Associated Risks, and Advances in Management\u2014A Narrative Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14030762"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Cioboata, R., Balteanu, M.A., Osman, A., Vlasceanu, S.G., Zlatian, O.M., Mitroi, D.M., Catana, O.M., Socaci, A., and Tieranu, E. (2025). Coinfections in Tuberculosis in Low- and Middle-Income Countries: Epidemiology, Clinical Implications, Diagnostic Challenges, and Management Strategies\u2014A Narrative Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14072154"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/5\/172\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:30:47Z","timestamp":1778765447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/5\/172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["diseases14050172"],"URL":"https:\/\/doi.org\/10.3390\/diseases14050172","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}